Van Lanschot Kempen Investment Management N.V. Reduces Position in Procter & Gamble Company (The) $PG

Van Lanschot Kempen Investment Management N.V. trimmed its holdings in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 22.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 185,209 shares of the company’s stock after selling 55,149 shares during the quarter. Van Lanschot Kempen Investment Management N.V.’s holdings in Procter & Gamble were worth $31,563,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nuveen LLC bought a new position in shares of Procter & Gamble during the first quarter valued at approximately $1,954,941,000. GAMMA Investing LLC lifted its position in Procter & Gamble by 20,758.5% in the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company’s stock worth $1,355,087,000 after purchasing an additional 7,913,335 shares during the period. Northern Trust Corp lifted its position in Procter & Gamble by 10.1% in the fourth quarter. Northern Trust Corp now owns 29,395,208 shares of the company’s stock worth $4,928,107,000 after purchasing an additional 2,703,757 shares during the period. Invesco Ltd. lifted its position in Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Procter & Gamble by 15.8% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company’s stock worth $2,728,430,000 after purchasing an additional 2,224,912 shares during the period. 65.77% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

PG has been the subject of a number of recent research reports. BNP Paribas reiterated an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a research report on Friday. Morgan Stanley set a $180.00 price target on shares of Procter & Gamble and gave the stock an “overweight” rating in a research note on Friday, April 25th. Royal Bank Of Canada upgraded shares of Procter & Gamble from a “sector perform” rating to an “outperform” rating and upped their price objective for the stock from $164.00 to $177.00 in a report on Friday, April 25th. Barclays set a $164.00 price objective on shares of Procter & Gamble and gave the stock an “equal weight” rating in a report on Thursday, July 31st. Finally, Wells Fargo & Company decreased their price target on shares of Procter & Gamble from $175.00 to $173.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Seven equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average price target of $175.94.

Check Out Our Latest Report on Procter & Gamble

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $155.68 on Tuesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. Procter & Gamble Company has a one year low of $149.91 and a one year high of $180.43. The firm has a 50 day simple moving average of $157.05 and a 200 day simple moving average of $163.17. The company has a market cap of $364.66 billion, a price-to-earnings ratio of 23.91, a PEG ratio of 4.07 and a beta of 0.37.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. During the same period in the prior year, the company posted $1.40 earnings per share. Procter & Gamble’s revenue for the quarter was up 1.7% compared to the same quarter last year. Research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble’s dividend payout ratio (DPR) is 64.98%.

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.